CoChat
Sign Up
Cited by 150

miR-191: an emerging player in disease biology

Nagpal, Neha, Kulshreshtha, Ritu·2014·Frontiers in Genetics
DOI 10.3389/fgene.2014.00099PMC PMC4005961
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fgene.2014.00099

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other miRNAs that are highly conserved in metazoans or known to be expressed in myeloid cells, including miR-191-5p, miR-15a-5p, miR-206, miR-335-5p, and miR-339-3p, showed moderate expression levels.

    “Other miRNAs that are highly conserved in metazoans or known to be expressed in myeloid cells, including miR-191-5p (ref. 53), miR-15a-5p (ref. 54), miR-206 (ref. 55), miR-335-5p (ref. 56), and miR-339-3p (ref. 56), were included and used as positive controls, and showed moderate expression levels.”

    From An integrated expression atlas of miRNAs and their promoters in human and mouse (2017) · cites this paper as [53]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 85

  1. Altuvia Y. Landgraf P. Lithwick G. Elefant N. Pfeffer S. Aravin A. (2005). Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. 33 2697– 2706 10.1093/nar/gki567 15891114 PMC1110742 · DOI
  2. Bartel D. P. Chen C. Z. (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5 396– 400 10.1038/nrg1328 15143321 · DOI
  3. Brenu E. W. Ashton K. J. van Driel M. Staines D. R. Peterson D. Atkinson G. M. (2012). Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J. Affect. Disord. 141 261– 269 10.1016/j.jad.2012.03.037 22572093 · DOI
  4. Cai S. Lee C. C. Kohwi-Shigematsu T. (2006). SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat. Genet. 38 1278– 1288 10.1038/ng1913 17057718 · DOI
  5. Caramuta S. Egyházi S. Rodolfo M. Witten D. Hansson J. Larsson C. (2010). MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J. Invest. Dermatol. 130 2062– 2070 10.1038/jid.2010.63 20357817 · DOI
  6. Cekaite L. Clancy T. Sioud M. (2010). Increased miR-21 expression during human monocyte differentiation into DCs. Front. Biosci. (Elite Ed.) 2: 818– 828 10.2741/E143 20515755 · DOI
  7. Chaudhry M. A. Omaruddin R. A. Brumbaugh C. D. Tariq M. A. Pourmand N. (2013). Identification of radiation-induced microRNA transcriptome by next-generation massively parallel sequencing. J. Radiat. Res. 54 808– 822 10.1093/jrr/rrt014 23447695 PMC3766286 · DOI
  8. Choi S. Y. Yun J. Lee O. J. Han H. S. Yeo M. K. Lee M. A. (2013). MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarray. Placenta 34 799– 804 10.1016/j.placenta.2013.06.006 23830491 · DOI
  9. Colamaio M. Borbone E. Russo L. Bianco M. Federico A. Califano D. (2011). miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. J. Clin. Endocrinol. Metab. 96 E1915– E1924 10.1210/jc.2011-0408 21956418 · DOI
  10. Crawford B. E. Garner O. B. Bishop J. R. Zhang D. Y. Bush K. T. Nigam S. K. (2010). Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS ONE 5: e10691 10.1371/journal.pone.0010691 PMC2872662 20502530 · DOI
  11. Davidson L. A. Wang N. Shah M. S. Lupton J. R. Ivanov I. Chapkin R. S. (2009). n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30 2077– 2084 10.1093/carcin/bgp245 19825969 PMC2792315 · DOI
  12. Depamphilis M. L. de Renty C. M. Ullah Z. Lee C. Y. (2012). “The octet”: eight protein kinases that control mammalian DNA replication. Front. Physiol. 3: 368 10.3389/fphys.2012.00368 PMC3458233 23055977 · DOI
  13. Di Leva G. Piovan C. Gasparini P. Ngankeu A. Taccioli C. Briskin D. (2013). Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet. 9: e1003311 10.1371/journal.pgen.1003311 PMC3591271 23505378 · DOI
  14. Duan Z. Choy E. Harmon D. Liu X. Susa M. Mankin H. (2011). MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol. Cancer Ther. 10 1337– 1345 10.1158/1535-7163.MCT-11-0096 21666078 PMC3711153 · DOI
  15. Elyakim E. Sitbon E. Faerman A. Tabak S. Montia E. Belanis L. (2010). hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 70 8077– 8087 10.1158/0008-5472.CAN-10-1313 20924108 · DOI
  16. Ernest N. Chen G. Chang A. C. Lin J. Reddy R. Orringer M. B. (2012). Ratio of miR-146b/miR-191 in serum predicts prognosis in surgically resected lung squamous cell carcinomas. Cancer Res. 72: 4147 10.1158/1538-7445.AM2012-4147 · DOI
  17. Fassan M. Baffa R. Palazzo J. P. Lloyd J. Crosariol M. Liu C. G. (2009). MicroRNA expression profiling of male breast cancer. Breast Cancer Res. 11: R58 10.1186/bcr2348 PMC2750120 19664288 · DOI
  18. Ferretti E. De Smaele E. Po A. Di Marcotullio L. Tosi E. Espinola M. S. (2009). MicroRNA profiling in human medulloblastoma. Int. J. Cancer 124 568– 577 10.1002/ijc.23948 18973228 · DOI
  19. Fulci V. Colombo T. Chiaretti S. Messina M. Citarella F. Tavolaro S. (2009). Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Genes Chromosomes Cancer 48 1069– 1082 10.1002/gcc.20709 19760605 · DOI
  20. Garzon R. Volinia S. Liu C. G. Fernandez-Cymering C. Palumbo T. Pichiorri F. (2008). MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111 3183– 3189 10.1182/blood-2007-07-098749 18187662 PMC2265455 · DOI
  21. Gombos K. Horváth R. Szele E. Juhász K. Gocze K. Somlai K. (2013). miRNA expression profiles of oral squamous cell carcinomas. Anticancer Res. 33 1511– 1517 23564792
  22. Griffiths-Jones S. Grocock R. J. van Dongen S. Bateman A. Enright A. J. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34 D140– D144 10.1093/nar/gkj112 16381832 PMC1347474 · DOI
  23. Han H. J. Russo J. Kohwi Y. Kohwi-Shigematsu T. (2008). SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452 187– 193 10.1038/nature06781 18337816 · DOI
  24. He Y. Cui Y. Wang W. Gu J. Guo S. Ma K. (2011). Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma. Neoplasia 13 841– 853 21969817 PMC3182276
  25. Hui A. B. Shi W. Boutros P. C. Miller N. Pintilie M. Fyles T. (2009). Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab. Invest. 89 597– 606 10.1038/labinvest.2009.12 19290006 · DOI
  26. Inoue T. Iinuma H. Ogawa E. Inaba T. Fukushima R. (2012). Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol. Rep. 27 1759– 1764 10.3892/or.2012.1709 22407237 · DOI
  27. Iorio M. V. Ferracin M. Liu C. G. Veronese A. Spizzo R. Sabbioni S. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 7065– 7070 10.1158/0008-5472.CAN-05-1783 16103053 · DOI · Paper page
  28. Izzotti A. Calin G. A. Arrigo P. Steele V. E. Croce C. M De Flora S. (2009). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J. 23 806– 812 10.1096/fj.08-121384 18952709 PMC2653990 · DOI
  29. Kasashima K. Nakamura Y. Kozu T. (2004). Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 322 403– 410 10.1016/j.bbrc.2004.07.130 15325244 · DOI
  30. Kashiwagi M. Tortorella M. Nagase H. Brew K. (2001). TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276 12501– 12504 10.1074/jbc.C000848200 11278243 · DOI
  31. Kent O. A. Mullendore M. Wentzel E. A. López-Romero P. Tan A. C. Alvarez H. (2009). A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol. Ther. 8 2013– 2024 10.4161/cbt.8.21.9685 20037478 PMC2824894 · DOI
  32. Kiezun A. Artzi S. Modai S. Volk N. Isakov O. Shomron N. (2012). miRviewer: a multispecies microRNA homologous viewer. BMC Res. Notes 5: 92 10.1186/1756-0500-5-92 PMC3292992 22330228 · DOI
  33. Kim J. Krichevsky A. Grad Y. Hayes G. D. Kosik K. S. Church G. M. (2004). Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl. Acad. Sci. U.S.A. 101 360– 365 10.1073/pnas.2333854100 14691248 PMC314190 · DOI
  34. Kumar P. Dezso Z. MacKenzie C. Oestreicher J. Agoulnik S. Byrne M. (2013). Circulating miRNA biomarkers for Alzheimer’ s disease. PLoS ONE 8: e69807 10.1371/journal.pone.0069807 PMC3726785 23922807 · DOI
  35. Lagos-Quintana M. Rauhut R. Meyer J. Borkhardt A. Tuschl T. (2003). New microRNAs from mouse and human. RNA 9 175– 179 10.1261/rna.2146903 12554859 PMC1370382 · DOI · Paper page
  36. Landi M. T. Chatterjee N. Caporaso N. E. Rotunno M. Albanes D. Thun M. (2010). GPC5 rs2352028 variant and risk of lung cancer in never smokers. Lancet Oncol. 11 714– 716 10.1016/S1470-2045(10)70096-6 20688270 PMC3238679 · DOI
  37. Leite K. R. Tomiyama A. Reis S. T. Sousa-Canavez J. M. Sañudo A. Camara-Lopes L. H. (2013). MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol. Oncol. 31 796– 801 10.1016/j.urolonc.2011.07.002 21880514 · DOI
  38. Leite K. R. Tomiyama A. Reis S. T. Sousa-Canavez J. M. Sañudo A. Dall’Oglio M. F. (2011). MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J. Urol. 185 1118– 1122 10.1016/j.juro.2010.10.035 21255804 · DOI
  39. Lena A. M. Mancini M. Rivetti di Val Cervo P. Saintigny G. Mahé C. Melino G. (2012). MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation. Biochem. Biophys. Res. Commun. 423 509– 514 10.1016/j.bbrc.2012.05.153 22683624 PMC3400053 · DOI
  40. Li X. Zhang Y. Zhang H. Liu X. Gong T. Li M. (2011). miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 9 824– 833 10.1158/1541-7786.MCR-10-0529 21628394 · DOI
  41. Lin J. Cao Q. Zhang J. Li Y. Shen B. Zhao Z. (2013). MicroRNA expression patterns in indeterminate inflammatory bowel disease. Mod. Pathol. 26 148– 154 10.1038/modpathol.2012.131 22899284 · DOI
  42. Liu C. Iqbal J. Teruya-Feldstein J. Shen Y. Dabrowska M. J. Dybkaer K. (2013a). MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma. Blood 122 2083– 2092 10.1182/blood-2012-08-447375 23801630 PMC3778551 · DOI
  43. Liu J. Tang X. Li M. Lu C. Shi J. Zhou L. (2013b). Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility. Breast Cancer Res. Treat. 140 151– 157 10.1007/s10549-013-2615-x 23793604 · DOI
  44. Liu L. Fan L. Fang C. Zou Z. J. Yang S. Zhang L. N. (2012). S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia. Cancer Sci. 103 2056– 2063 10.1111/cas.12008 22937789 PMC7659220 · DOI
  45. Luo Y. Wang C. Chen X. Zhong T. Cai X. Chen S. (2013). Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin. Chem. 59 658– 666 10.1373/clinchem.2012.195297 23344497 · DOI
  46. Mar-Aguilar F. Luna-Aguirre C. M. Moreno-Rocha J. C. Araiza-Chávez J. Trevino V. Rodriquez-Padilla C. (2013a). Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia Pac. J. Clin. Oncol. 9 53– 59 10.1111/j.1743-7563.2012.01548.x 22898264 · DOI
  47. Mar-Aguilar F. Mendoza-Ramírez J. A. Malagón-Santiago I. Espino-Silva P. K. Santuario-Facio S. K. Ruiz-Flores P. (2013b). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis. Markers 34 163– 169 10.1155/2013/259454 23334650 PMC3810231 · DOI
  48. McEvoy J. Ulyanov A. Brennan R. Wu G. Pounds S. Zhang J. (2012). Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. PLoS ONE 7: e42739 10.1371/journal.pone.0042739 PMC3423419 22916154 · DOI · Paper page
  49. Mellios N. Huang H. S. Grigorenko A. Rogaev E. Akbarian S. (2008). A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum. Mol. Genet. 17 3030– 3042 10.1093/hmg/ddn201 18632683 PMC2722882 · DOI · Paper page
  50. Meng W. J. Yan H. Zhou B. Zhang W. Kong X. H. Wang R. (2012). Correlation of SATB1 overexpression with the progression of human rectal cancer. Int. J. Colorectal Dis. 27 143– 150 10.1007/s00384-011-1302-9 21870058 · DOI
  51. Monzo M. Navarro A. Bandres E. Artells R. Moreno I. Gel B. (2008). Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 18 823– 833 10.1038/cr.2008.81 18607389 · DOI
  52. Mueller D. W. Rehli M. Bosserhoff A. K. (2009). miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J. Invest. Dermatol. 129 1740– 1751 10.1038/jid.2008.452 19212343 · DOI
  53. Na Y. J. Sung J. H. Lee S. C. Lee Y. J. Choi Y. J. Park W. Y. (2009). Comprehensive analysis of microRNA-mRNA co-expression in circadian rhythm. Exp. Mol. Med. 41 638– 647 10.3858/emm.2009.41.9.070 19478556 PMC2753657 · DOI
  54. Nagpal N. Ahmad H. M. Molparia B. Kulshreshtha R. (2013). MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis 34 1889– 1899 10.1093/carcin/bgt107 23542418 · DOI
  55. Numakawa T. Matsumoto T. Numakawa Y. Richards M. Yamawaki S. Kunugi H. (2011). Protective action of neurotrophic factors and estrogen against oxidative stress-mediated neurodegeneration. J. Toxicol. 2011: 405194 10.1155/2011/405194 PMC3135156 21776259 · DOI
  56. Palmieri A. Pezzetti F. Brunelli G. Martinelli M. Lo Muzio L. Scarano A. (2010). Anorganic bovine bone (Bio-Oss) regulates miRNA of osteoblast-like cells. Int. J. Periodontics Restorative Dent. 30 83– 87 20224834
  57. Pan X. Zhao J. Zhang W. N. Li H. Y. Mu R. Zhou T. (2009). Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc. Natl. Acad. Sci. U.S.A. 106 3788– 3793 10.1073/pnas.0810147106 19234109 PMC2656158 · DOI
  58. Paraskevi A. Theodoropoulosb G. Papaconstantinouc I. Mantzarisd G. Nikitease N. Gazoulia M. (2012). Circulating MicroRNA in inflammatory bowel disease. J. Crohns Colitis 6 900– 904 10.1016/j.crohns.2012.02.006 22386737 · DOI
  59. Patel R. S. Jakymiw A. Yao B. Pauley B. A. Carcamo W. C. Katz J. (2011). High resolution of microRNA signatures in human whole saliva. Arch. Oral Biol. 56 1506– 1513 10.1016/j.archoralbio.2011.05.015 21704302 PMC3189266 · DOI
  60. Patnaik S. K. Kannisto E. Yendamuri S. (2010). Overexpression of microRNA miR-30a or miR-191 in A549 lung cancer or BEAS-2B normal lung cell lines does not alter phenotype. PLoS ONE 5: e9219 10.1371/journal.pone.0009219 PMC2821397 20169152 · DOI
  61. Poliseno L. Haimovic A. Segura M. F. Hanniford D. Christos P. J. Darvishian F. (2012). Histology-specific microRNA alterations in melanoma. J. Invest. Dermatol. 132 1860– 1868 10.1038/jid.2011.451 22551973 PMC3648670 · DOI
  62. Qin S. Zhu Y. Ai F. Li Y. Bai B. Yao W. (2014). MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. Neoplasma 61 27– 34 10.4149/neo_2014_005 24195505 · DOI
  63. Rhodes D. R. Yu J. Shanker K. Deshpande N. Varambally R. Ghosh D. (2004). Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. U.S.A. 101 9309– 9314 10.1073/pnas.0401994101 15184677 PMC438973 · DOI
  64. Robker R. L. Richards J. S. (1998). Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol. Endocrinol. 12 924– 940 10.1210/mend.12.7.0138 9658398 · DOI
  65. Saad R. Chen Z. Zhu S. Jia P. Zhao Z. Washington M. K. (2013). Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS ONE 8: e64463 10.1371/journal.pone.0064463 PMC3665888 23724052 · DOI
  66. Saba R. Goodman C. D. Huzarewich R. L. Robertson C. Booth S. A. (2008). A miRNA signature of prion induced neurodegeneration. PLoS ONE 3: e3652 10.1371/journal.pone.0003652 PMC2575400 18987751 · DOI · Paper page
  67. Scheffer A. R. Holdenrieder S. Kristiansen G. von Ruecker A. Müller S. C. Ellinger J. (2014). Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J. Urol. 32 353– 358 10.1007/s00345-012-1010-2 23266581 · DOI
  68. Shen J. DiCioccio R. Odunsi K. Lele S. B. Zhao H. (2010). Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer 10: 47 10.1186/1471-2407-10-47 PMC2831822 20167074 · DOI
  69. Sheng J. Liu R. Xu Y. Liu J. (2011). The dominating role of N-deacetylase/N-sulfotransferase 1 in forming domain structures in heparan sulfate. J. Biol. Chem. 286 19768– 19776 10.1074/jbc.M111.224311 21454625 PMC3103355 · DOI
  70. Shi X. Su S. Long J. Mei B. Chen Y. (2011). MicroRNA-191 targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803. Acta Biochim. Biophys. Sin. (Shanghai) 43 849– 856 10.1093/abbs/gmr084 21947487 · DOI
  71. Taguchi Y. H. Murakami Y. (2013). Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers. PLoS ONE 8: e66714 10.1371/journal.pone.0066714 PMC3715582 23874370 · DOI
  72. Vaz C. Ahmad H. M. Sharma P. Gupta R. Kumar L. Kulshreshtha R. (2010). Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics 11: 288 10.1186/1471-2164-11-288 PMC2885365 20459673 · DOI
  73. Volinia S. Calin G. A. Liu C. G. Ambs S. Cimmino A. Petrocca F. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103 2257– 2261 10.1073/pnas.0510565103 16461460 PMC1413718 · DOI · Paper page
  74. Wei C. Henderson H. Spradley C. Li L. Kim I. K. Kumar S. (2013). Circulating miRNAs as potential marker for pulmonary hypertension. PLoS ONE 8: e64396 10.1371/journal.pone.0064396 PMC3662705 23717609 · DOI
  75. Wynendaele J. Böhnke A. Leucci E. Nielsen S. J. Lambertz I. Hammer S. (2010). An illegitimate microRNA target site within the 3’ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res. 70 9641– 9649 10.1158/0008-5472.CAN-10-0527 21084273 · DOI
  76. Xi Y. Formentini A. Chien M. Weir D. B. Russo J. J. Ju J. (2006). Prognostic values of microRNAs in colorectal cancer. Biomark. Insights 2 113– 121 18079988 PMC2134920
  77. Xu G. Zhang Y. Jia H. Li J. Liu X. Engelhardt J. F. (2009). Cloning and identification of microRNAs in bovine alveolar macrophages. Mol. Cell. Biochem. 332 9– 16 10.1007/s11010-009-0168-4 19507003 · DOI
  78. Xu L. Liang Y. N. Luo X. Q. Liu X. D. Guo H. X. (2011). [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi 32 178– 181 21535956
  79. Yan S. F. Pinsky D. J. Mackman N. Stern D. M. (2000). Egr-1: is it always immediate and early? J. Clin. Invest. 105 553– 554 10.1172/JCI9513 10712422 PMC292461 · DOI
  80. Yanaihara N. Caplen N. Bowman E. Seike M. Kumamoto K. Yi M. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 189– 198 10.1016/j.ccr.2006.01.025 16530703 · DOI · Paper page
  81. Zampetaki A. Kiechl S. Drozdov I. Willeit P. Mayr U. Prokopi M. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107 810– 817 10.1161/CIRCRESAHA.110.226357 20651284 · DOI
  82. Zhang H. Luo X. Q. Zhang P. Huang L. B. Zheng Y. S. Wu J. (2009). MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE 4: e7826 10.1371/journal.pone.0007826 PMC2773830 19915715 · DOI
  83. Zhang L. Flygare J. Wong P. Lim B. Lodish H. F. (2011). miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev. 25 119– 124 10.1101/gad.1998711 21196494 PMC3022257 · DOI
  84. Zhou J. Zhou Y. Yin B. Hao W. Zhao L. Ju W. (2010). 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro. Oncol. Rep. 23 121– 128 10.3892/or_00000613 19956872 · DOI
  85. Zhou L. Zhang X. Li Z. Zhou C. Li M. Tang X. (2013). Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma. PLoS ONE 8: e64331 10.1371/journal.pone.0064331 PMC3665831 23724042 · DOI

Cited by

Sorted by citations

Authors
Nagpal, N., & Kulshreshtha, R.
Venue
Frontiers in Genetics
Publisher
Frontiers Media SA
Published
2014-04-23
Volume
5
ISSN
1664-8021
DOI
10.3389/fgene.2014.00099
PMC
PMC4005961
Cited by
150
References
0

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review